S&P 500 Futures
(0.06%) 5 311.50 points
Dow J Futures
(0.07%) 40 173 points
Nasdaq Futures
(0.10%) 18 523 points
Oil
(1.68%) $82.72
Gas
(0.12%) $1.720
Gold
(0.85%) $2 231.50
Silver
(-0.08%) $24.73
Platinum
(0.49%) $914.20
USD/EUR
(0.33%) $0.926
USD/NOK
(0.57%) $10.83
USD/GBP
(0.10%) $0.792
USD/RUB
(-0.08%) $92.37

Realtime updates for Crinetics Pharmaceuticals [CRNX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
80.00%
return -2.31%
SELL
40.00%
return 0.89%
Last Updated27 Mar 2024 @ 16:00

2.44% $ 44.43

BUY 61433 min ago

@ $36.22

Issued: 14 Feb 2024 @ 15:47


Return: 22.67%


Previous signal: Feb 14 - 12:28


Previous signal: Sell


Return: -0.41 %

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors...

Stats
Today's Volume 823 483
Average Volume 744 927
Market Cap 3.46B
EPS $0 ( 2024-02-28 )
Next earnings date ( $-0.840 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -12.04
ATR14 $0.0380 (0.09%)
Insider Trading
Date Person Action Amount type
2024-03-22 Knight Jeff E. Sell 30 000 Stock Option (right to buy)
2024-03-22 Knight Jeff E. Buy 30 000 Common Stock
2024-03-22 Knight Jeff E. Sell 30 000 Common Stock
2024-03-22 Knight Jeff E. Sell 2 359 Common Stock
2024-03-20 Pizzuti Dana Sell 4 375 Stock Option (right to buy)
INSIDER POWER
25.92
Last 99 transactions
Buy: 1 520 833 | Sell: 975 029

Volume Correlation

Long: -0.13 (neutral)
Short: 0.79 (moderate)
Signal:(59.497) Neutral

Crinetics Pharmaceuticals Correlation

10 Most Positive Correlations
VYNE0.883
CPIX0.875
FULC0.871
ARWR0.869
RDUS0.866
LITM0.861
RNDM0.858
SPRO0.857
JAKK0.844
ENTA0.841
10 Most Negative Correlations
ALGM-0.894
SITM-0.856
GMII-0.853
PPBT-0.85
GDRX-0.835
UMPQ-0.821
GFS-0.815
SBBP-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Crinetics Pharmaceuticals Correlation - Currency/Commodity

The country flag -0.05
( neutral )
The country flag -0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.17
( neutral )
The country flag 0.26
( neutral )
The country flag 0.05
( neutral )

Crinetics Pharmaceuticals Financials

Annual 2023
Revenue: $4.01M
Gross Profit: $2.92M (72.64 %)
EPS: $-3.69
Q4 2023
Revenue: $0
Gross Profit: $-262 000 (0.00 %)
EPS: $-0.900
Q3 2023
Revenue: $346 000
Gross Profit: $73 000.00 (21.10 %)
EPS: $-1.010
Q2 2023
Revenue: $988 000
Gross Profit: $590 000 (59.72 %)
EPS: $-0.940

Financial Reports:

No articles found.

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators